Sagimet Biosciences

(NASDAQ) SGMT

Current Price$7.04

Market Cap$435.97M

Since IPO (2023)-56%

5 YearN/A

1 Year-16%

1 Month-0%

Sagimet Biosciences Financials at a Glance

Market Cap

$435.97M

Revenue (TTM)

$0.00

Net Income (TTM)

-$43.51M

EPS (TTM)

-$1.34

P/E Ratio

-5.26

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$7.04

Volume

2,849

Open

$7.00

Price

$7.04

Volume

2,849

Open

$7.00

Previous Close

$7.06

Daily Range

$7.00 - $7.34

52-Week Range

$4.50 - $11.41

Estimated Earnings Date

May 20, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$7.04

Volume

2,849

Open

$7.00

Previous Close

$7.06

Daily Range

$7.00 - $7.34

52-Week Range

$4.50 - $11.41

Estimated Earnings Date

May 20, 2026

SGMT News

Why Sagimet Biosciences Stock Is Soaring Today

James BrumleyApr 27, 2026

Sagimet Biosciences Tops Q2 EPS Forecast

Motley Fool Markets TeamAug 13, 2025

SGMT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sagimet Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David A. Happel, MBA

Website

www.sagimet.com

Headquarters

San Mateo, CA 94402, US

SGMT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-37.57%

Return on Capital

-51.04%

Return on Assets

-40.38%

Earnings Yield

-19.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$435.97M

Shares Outstanding

61.75M

Volume

2.85K

Avg. Volume

1.58M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$48.74M

EBITDA

-$46.14M

Operating Cash Flow

-$39.73M

Capital Expenditure

$0.00

Free Cash Flow

-$39.73M

Cash & ST Invst.

$104.54M

Total Debt

$39.00K

Sagimet Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$435.97M

N/A

Market Cap/Employee

$27.25M

N/A

Employees

N/A

Net Income

-$10.65M

+41.4%

EBITDA

-$10.65M

+41.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$104.54M

-27.7%

Total Debt

$39.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$39.00K

+0.0%

Return on Assets

-40.38%

N/A

Return on Invested Capital

-47.57%

N/A

Free Cash Flow

-$8.61M

+40.8%

Operating Cash Flow

-$8.61M

+40.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ASMBAssembly Biosciences, Inc.

ASMBAssembly Biosciences, Inc.$26.80+6.56%

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$4.48+2.05%

ACHVAchieve Life Sciences, Inc.

ACHVAchieve Life Sciences, Inc.$5.01-1.76%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$7.24+2.40%

ZURAZura Bio Limited

ZURAZura Bio Limited$4.31+1.77%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.14-0.96%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.70-0.54%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$157.09+0.02%

INTCIntel

INTCIntel$132.39-0.06%

NVDANvidia

NVDANvidia$200.32-0.04%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$714.70-0.03%

AAPLApple

AAPLApple$294.83-0.01%

NOKNokia

NOKNokia$13.70-0.05%

TSLATesla

TSLATesla$382.02-0.06%

Questions About SGMT

What is the current price of Sagimet Biosciences?

Sagimet Biosciences is trading at $7.06 per share.

What is the 52-week range for Sagimet Biosciences?

Over the past 52 weeks, Sagimet Biosciences has traded between $4.50 and $11.41.

How much debt does Sagimet Biosciences have?

As of the most recent reporting period, Sagimet Biosciences reported total debt of $39.00K.

How much cash does Sagimet Biosciences have on hand?

Sagimet Biosciences reported $36.63M in cash and cash equivalents in its most recent financial results.

What is Sagimet Biosciences’s dividend yield?

Sagimet Biosciences does not currently have a dividend yield.

Sagimet Biosciences

Sagimet Biosciences Financials at a Glance

SGMT News

Why Sagimet Biosciences Stock Is Soaring Today

Sagimet Biosciences Tops Q2 EPS Forecast

SGMT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sagimet Biosciences

SGMT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sagimet Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SGMT

What is the current price of Sagimet Biosciences?

What is the 52-week range for Sagimet Biosciences?

How much debt does Sagimet Biosciences have?

How much cash does Sagimet Biosciences have on hand?

What is Sagimet Biosciences’s dividend yield?

Premium Investing Services